Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations (Japanese corporate name Genesis Healthcare Co.), one of Japan’s leading genetic testing companies, today announce an international collaboration to develop and deploy advanced genomic sequencing and medicine applications based on comprehensive, nanopore sequencing in Japan. In […]
The designation builds on the unit’s role as the first G4X Early Access Program site and supports broader global adoption of G4X. San Diego, CA and Boston, MA — Singular Genomics today announced that the Spatial Technologies Unit (STU) at Beth Israel Deaconess Medical Center (BIDMC), a Dana-Farber/Harvard Cancer Center (DF/HCC) Core Facility, has been designated a G4X™ Center of Excellence. The STU […]
Laboratories running wastewater surveillance, bloodstream pathogen detection, or urine-based STI screening no longer need to choose between sample volume and automation. SwiftXtractor™ SL processes up to 40 mL in a single run, replacing manual concentration steps that cost time, introduce variability, and limit throughput. Compact, portable, and ready for your bench. Hallbergmoos, Germany — […]
Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision BOULDER, CO – Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology, giving researchers scalable access to high purity 100-400nt RNA constructs for next-generation therapeutics. The agreement brings to market an approach developed […]
Genomenon’s Curation and Global Distribution of Variant Data Reduces Barriers to Genetic Diagnosis ANN ARBOR, Mich. – Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease. Through this collaboration, Genomenon produced literature-derived real-world evidence by applying fit-for-purpose AI and expert review to curate and classify variants in […]
First-in-class solution consolidates multiple assays into a single test, enabling broader viral detection, faster time-to-result and more confident decision-making in regulated biopharmaceutical quality control ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world’s first GMP-validated adventitious viral agent (AVA) detection test based on […]
70,000 sq. ft. facility expands the company’s biopharma, chemical and cold chain storage capacities DUBLIN, Ireland — Thermo Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution center in Bracetown, County Meath, Ireland. The facility significantly expands the company’s infrastructure in Ireland, one of the […]
IPSWICH, Mass. — New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, is extending its global subsidiary network with the opening of New England Biolabs India Pvt. Ltd. (NEB India) at Phoenix Asia Towers in Bengaluru, Karnataka, India. India has long been a global leader in the life […]
São Paulo, Brazil – MGI Tech Co., Ltd. (MGI), a company delicated to developing tools and technologies that drive innovation in life sciences, today announced a strategic partnership with NeoGenomica, a leading Brazilian laboratory specialising in advanced genetic testing. The collaboration aims to expand access to genomics applications in oncology, rare diseases, and precision medicine […]
Proven experience in leveraging AI in biology will strengthen the board of directors as PacBio develops data tools to maximize the power of HiFi sequencing MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio’s Board of Directors. Dr. Gibson […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
